The Pfizer Independent Grants for Learning & Change, on behalf of the Bristol-Myers Squibb – Pfizer Alliance and along with the AHSNs, have jointly issued a Request for Proposals designed to improve the care of patients with Atrial Fibrillation in order to reduce stroke risk.
This competitive grant programme is intended to support healthcare organisations in England to develop innovative projects that focus on:
It is expected that projects will be evidence-based education and/or quality improvement programmes.
Proposals from healthcare organisations must include a letter of support from an AHSN, but applications do not need to be directly from an AHSN team. Individual projects requesting up to a total of £100,000 will be considered. The total available budget related to this RFP is £400,000. The size of the grant the Alliance will be prepared to fund for any project will depend upon the AHSN external review panel's evaluation of the proposal and costs involved, and will be stated clearly in the approval notification.
The full proposal deadline is Thursday 8 September. For more details and to apply, visit the Pfizer website.